Donna R. Cryer, JD, has channeled her personal experience as an IBD and liver transplant patient into professional advocacy as president and chief executive officer of the Global Liver Institute, the innovation and collaboration platform for the liver community. For almost a decade Mrs. Cryer led CryerHealth, a healthcare consulting firm she founded, providing strategic counsel to top biopharmaceutical companies, patient advocacy organizations, and emerging technology firms on patient engagement in health information technology, drug discovery, and clinical decision making. She is a frequent speaker on the topic of patient-centeredness and patient engagement in healthcare transformation.
Mrs. Cryer serves on the Executive Committee of the People-Centered Research Foundation, the Boards of Directors of the Society for Participatory Medicine and the Personalized Medicine Coalition, as a patient representative to the U.S. Food and Drug Administration and the ABIM Gastroenterology Specialty Board. Mrs. Cryer’s community service also includes roles on the Boards of Trustees of Sibley Memorial Hospital/Johns Hopkins Medicine and The Taft School.
Previously, Mrs. Cryer was appointed by the U.S. GAO to serve as the patient and consumer representative on the Health Information Policy Committee, the federal advisory body to the National Coordinator for HIT, and as a merit reviewer for the Patient Centered Outcomes Research Institute (PCORI), a member of Stakeholder Advisory Group to the NIH Learning Health System Research Collaboratory, and on an American Society of Clinical Oncology Guidelines Committee.
Mrs. Cryer has been named one of the Top Blacks in Healthcare by the Milken Institute at GW School of Public Health and BlackDoctors.org, one of the Top 10 Patients Who Make An Impact by Health 2.0 and one of PharmaVoice’s 100 Most Inspiring People. Mrs. Cryer received an undergraduate degree from Harvard/Radcliffe Colleges and a Juris Doctorate from the Georgetown University Law Center.